Stock Research for mjna

mjna

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

mjna Stock Chart & Research Data

The mjna chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the mjna chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


mjna Due diligence Resources & Stock Charts

The mjna stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View mjna Detailed Price Forecast - CNN Money CNN View mjna Detailed Summary - Google Finance
Yahoo View mjna Detailed Summary - Yahoo! Finance Zacks View mjna Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View mjna Trends & Analysis - Trade-Ideas Barrons View mjna Major Holders - Barrons
NASDAQ View mjna Call Transcripts - NASDAQ Seeking View mjna Breaking News & Analysis - Seeking Alpha
Spotlight View mjna Annual Report - CompanySpotlight.com OTC Report View mjna OTC Short Report - OTCShortReport.com
TradeKing View mjna Fundamentals - TradeKing Charts View mjna SEC Filings - Bar Chart
WSJ View Historical Prices for mjna - The WSJ Morningstar View Performance/Total Return for mjna - Morningstar
MarketWatch View the Analyst Estimates for mjna - MarketWatch CNBC View the Earnings History for mjna - CNBC
StockMarketWatch View the mjna Earnings - StockMarketWatch MacroAxis View mjna Buy or Sell Recommendations - MacroAxis
Bullish View the mjna Bullish Patterns - American Bulls Short Pains View mjna Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View mjna Stock Mentions - StockTwits PennyStocks View mjna Stock Mentions - PennyStockTweets
Twitter View mjna Stock Mentions - Twitter Invest Hub View mjna Investment Forum News - Investor Hub
Yahoo View mjna Stock Mentions - Yahoo! Message Board Seeking Alpha View mjna Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for mjna - SECform4.com Insider Cow View Insider Transactions for mjna - Insider Cow
CNBC View mjna Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for mjna - OTC Markets
Yahoo View Insider Transactions for mjna - Yahoo! Finance NASDAQ View Institutional Holdings for mjna - NASDAQ


Stock Charts

FinViz View mjna Stock Insight & Charts - FinViz.com StockCharts View mjna Investment Charts - StockCharts.com
BarChart View mjna Stock Overview & Charts - BarChart Trading View View mjna User Generated Charts - Trading View




Latest Financial News for mjna


Medical Marijuana, Inc. Subsidiary Kannaway® Announces February 2021 as the Best Month in Company History for Japan Division
Posted on Wednesday March 03, 2021

SAN DIEGO, CA, March 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of its subsidiary Kannaway® had its best sales month ever in Company history in February 2021. “When we first entered the Japanese market in late 2019, we were one of the first companies offering cannabidiol (CBD) products in the country and saw a great opportunity to give consumers the high-quality products they had been asking for,” said Kannaway® CEO Blake Schroeder. “Since then, our team has done tremendous work expanding our reach and footprint in Japan.” The Japanese CBD market looks to continue rapidly expanding in the coming years. According to Research and Markets, the global CBD oil market is expected to reach $5.3 billion by 2025 with Asia-Pacific as one of the fastest-growing regions. “While leading our team in Japan, I have seen the positive response to our offerings in the country first-hand. Our team has shown what can be done with hard work and a distinguishing product offering and I look forward to our further growth,” said Kannaway® Japan Division General Manager Peter Dale. To learn more about Kannaway®, please visit the Company online at https://www.kannaway.com/. About Kannaway® Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products. About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here. Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop. FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein. FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. LEGAL DISCLOSURE Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act. CONTACT: Public Relations Contact: Kathryn Brown Account Supervisor CMW Media P. 858-264-6600 kathryn@cmwmedia.com www.cmwmedia.com Investor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.com


Medical Marijuana, Inc. Subsidiary Kannaway® Receives BSCG Certified Drug-Free Approval for Its Pure Gold CBD
Posted on Wednesday February 24, 2021

Pure Gold Recognized as Free of Substances Banned by US Anti-Doping Agency (USADA) and Professional Sports Leagues SAN DIEGO, CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has received Certified Drug Free approval from the Banned Substances Control Group (BSCG), a leading third-party certification and testing provider of dietary supplements and natural products, for its broad-spectrum cannabidiol (CBD) product Pure Gold. “As pioneers in the CBD industry, we were one of the first companies to conduct third-party testing on all of our products and provide those results to our customers,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “This certification furthers our dedication to providing athletes and general consumers alike the confidence to enjoy Pure Gold CBD without the fear of drug testing.” BSCG is the standard in testing for third-party certification that ensures products meet quality specifications and are not contaminated with drugs or agents that can lead to health concerns or positive drug tests. The BSCG Certified Drug Free program requires companies to submit their products through a thorough toxicology review, ingredient evaluation, Good Manufacturing Practices (GMP) quality control process review, and continual random product testing. It provides protection against drugs on the World Anti-Doping Agency (WADA) Prohibited List as well as prescription over-the-counter (OTC) and illicit drugs not banned in sports. “The greatest value that we can provide our customers with is trust and we aim to offer this time and time again by guaranteeing that our products are of the highest quality, safe, consistent, and accurately labeled,” said Kannaway® CEO Blake Schroeder. “We take every opportunity we are given to test and certify our products and hope that consumers see that as our commitment to them." To learn more about BSCG or view Kannaway’s certification, please visit https://kannaway.com/news/content/pure-gold-1500-mg-receives-certified-cbd-seal-by-bscg,4,822.html. About Kannaway® Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products. About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here. Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop. FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein. FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. LEGAL DISCLOSURE Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act. CONTACT: Public Relations Contact: Kathryn Brown Account Supervisor CMW Media P. 858-264-6600 kathryn@cmwmedia.com www.cmwmedia.com Investor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.com


Medical Marijuana, Inc. Subsidiary Kannaway® Submits Novel Foods Application for CBD Products Through European Industrial Hemp Association Consortium
Posted on Monday February 22, 2021

SAN DIEGO, CA, Feb. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has submitted its Novel Foods application for its cannabidiol (CBD) products to the UK’s Food Standards Agency (FSA) through the European Industrial Hemp Association (EIHA) Novel Foods Consortium. “We are witnessing a pivotal moment in history when the global appetite for free access to CBD for all people is very high,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We see this in the US with many recent positive discussions among US congressional officials to pass legislation for federal legalization of cannabis but also new bills for CBD to be regulated as a dietary supplement and food ingredient. In the United Kingdom, there are measures to secure that market’s unity, safety and efficacy for the sale of CBD. With regard to Europe, we could not be more excited to continue the push for free access to all." The EIHA Novel Food Consortium, formed in June 2020, allows Kannaway® to strengthen its commitment to provide free access to CBD-based products throughout the EU. Now that the application has been submitted to the FSA, the next step is to undertake the submission to the European Food Safety Authority (EFSA). “It is very encouraging to see the industry’s leading companies banding together to ensure free access,” said Kannaway® Managing Director of International Janne Heimonen. “We appreciate the EIHA and its other members for their unified efforts to bear the costs for the necessary toxicological studies and additional approval procedures.” About Kannaway® Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products. About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here. Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop. FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein. FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. LEGAL DISCLOSURE Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act. CONTACT: Public Relations Contact:Kathryn BrownAccount SupervisorCMW MediaP. 858-264-6600kathryn@cmwmedia.comwww.cmwmedia.com Investor Relations Contact:P. (858) 283-4016Investors@medicalmarijuanainc.com


One World Universe, Inc. in Negotiations With Medical Marijuana Inc. Subsidiary HempMeds® to Assist With Humanitarian Efforts
Posted on Wednesday February 17, 2021

HUNTINGTON BEACH, CA, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- One World Universe Inc. (OTC: OWUV), a publicly traded company that invests in business opportunities within emerging industries and provides humanitarian efforts in over 185 countries, has announced it is in negotiations with HempMeds®, a subsidiary of Medical Marijuana, Inc. (OTC: MJNA) which will enhance One World’s medicinal product pipeline being distributed throughout their emerging 3rd world network. Jerry C. Craig, CEO of One World, stated, “We are proud to stand with the brave pioneers, entrepreneurs and scientists who have continued to educate and advocate for CBD and marijuana as a medication and all its healing properties. For the majority of the people who are aware and have personally experienced the vast benefits of CBD, we stand with you. As we knew then, we surely know now just how valuable CBD and medical marijuana is to people of all walks of life throughout the world. It is with great pleasure and honor to announce our plans for helping and bringing valuable CBD products from the best growers, producers and scientists that the world has to offer as part of our humanitarian efforts and changing America as only One World can.” HempMeds was founded on the premises of providing help to as many as possible with the knowledge that one will only be stronger by providing support to those around you. “As someone who knows firsthand how CBD can change a person’s life in seeing it in my own daughter and around this industry, we all have a responsibility to be present,” said Raul Elizalde, HempMeds President. “There is such a profound need - How can we not answer the call? HempMeds’ mission since its inception is that if we can help change just one life, all the struggles and fights to get the CBD industry where it is today would have been worth it. This unique partnership allows us to exceed that goal in such an unimaginable scale. HempMeds is humbled and looking forward to building lasting relationships with OWUV, its family of companies, partnerships and the global changes that will follow,” said Michelle Sides, Co-Founder of MJNA. Management has been aggressively brandishing relationships and pursuing fortune 500-type business partners, sponsors and non-profit organizations with the commitment to changing America as only One World can. One World’s business model through the sale of products and services such as sporting equipment, personal protective equipment (PPE), diagnostic testing kits, cannabis and various medical services and supplies will help fund and change the lives of young athletes and the less fortunate around the world. For additional updates and information, shareholders are asked to follow our social media account on Twitter at www.twitter.com/JCHC_UPWT and www.twitter.com/oneworldu or visit our website at www.oneworlduniverseinc.com and www.JCHoldingCorp.com. About One World Universe, Inc. One World Universe (OTC:OWUV) is a California based benefits corporation whose mission driven business is implementing global humanitarian efforts through the profits generated from the sales of products and services to improve people's lives living in the harshest environments and their communities. For over a decade, our company has contributed valuable resources such as access to (PPE) personal protective equipment, medications, vaccines and educational support programs all while promoting champion play through soccer balls and other innovating projects where play and basic necessities are essential. About HempMeds® Founded in 2012, HempMeds® was the first company to bring hemp-based cannabidiol (CBD) oil products to market in the U.S. As a subsidiary of Medical Marijuana, Inc., HempMeds is the exclusive distributor for premium brands including Real Scientific Hemp Oil™ and Dixie Botanicals®, and operates in all 50 states and 40 countries. HempMeds® is the only company to have its CBD products listed in the Prescribers’ Digital Reference (PDR), the only company invited to speak to the World Health Organization and FDA on the benefits of CBD, and one of the first to be certified by the U.S. Hemp Authority. To learn more, please visit www.hempmedspx.com. About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here. Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop. Forward-Looking Statements Disclaimer: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov and in OTC Markets at www.otcmarkets.com Investor Relations Contact Dana Salzarulo Director Investor Relations Info@jcholdingcorp.com 1-833-333-5242 Office


Stock Market & Investing Books

Enter a stock symbol to view the stock details.